Log in to your Inderes Free account to see all free content on this page.

Vicore Pharma Holding

9.98 SEK

-0.40%

Less than 1K followers

VICO

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vicore Pharma Holding

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)14.3030.6513.5417.4213.808.4511.30
Shares44.362.173.884.1114.8234.6281.5
Market cap633.51,903.2998.91,465.11,584.21,982.23,181.2
Enterprise value446.11,584.6627.71,203.31,101.5826.2-
EV/S-----7.6-
EV/EBITDAneg.neg.neg.neg.neg.neg.-
EV/EBITneg.neg.neg.neg.neg.neg.-
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B1.975.372.615.073.481.762.90
P/S-----18.1833.4
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio94.3 %87.2 %85.0 %85.4 %91.8 %93.9 %89.8 %
Gearing ratio0.1 %0.0 %0.1 %----
Login required

This content is only available for logged in users